It was a rock star during the coronavirus pandemic, but Pfizer (NYSE: PFE) hasn't been the most exciting company in 2024. Its stock has become something of a value play, at least according to one ...
Based on the WallStreet consensus for $4.25 in earnings per share in 2024 ... Meanwhile, the guidance from the investor day in March calls for $7.1 billion to $7.5 billion in 2025, reaching $10 ...
Yet, despite its tremendous run, some on WallStreet believe there's a long runway ahead. Let's look at what distinguishes Palantir and whether the stock is still a buy. Palantir has been at the ...
Some results have been hidden because they may be inaccessible to you